In Germany alone, the health care costs due to secondary infections are estimated at up to 7 billion Euros annually. Some the largest risk factors in medical treatment are postoperative and nosocomial infections as well as the increasing presence of antibiotic resistant pathogens. According to current numbers, it is assumed that 800,000 patients per year (incl. about 40,000 deaths) are infected in hospitals. Safe and flexible hygiene procedures are the basis for minimizing infection risks.
In particular, thermolabile micro- and tube systems, instruments, implants, and cell-therapeutic agents cannot be sterilized using the current hospital practice of hot steam sterilization methods. This is because of the high temperatures that are necessary for a long period. New sterilization technologies can thus reduce the enormous psychological and physical burden on affected patients. In addition, they can lead to high cost savings in health care.